The South Korean government seems to be still lingering on the notion of restricting the joint bioequivalence test the Regulatory Reform Committee has put a brake on.

At the recently convened National Assembly Annual Audit, Minister Lee Eui-kyung of Food and Drug Safety stated that she “fundamentally agrees with the restricting the ‘one-plus-three’ joint bioequivalence test.” The minister’s agreement was expressed on the regulatory bill introduced to the National Assembly to only approve of up to three generics using a single source of consigned bioequivalence tests.

With the lawmaker’s boost, the ministry is rekindling the effort to legislate the restriction on joint bioequivale